Anantharaman Muthuswamy

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Age Related Macular Degeneration

Optical Coherence Tomography

Top Venues

Toxicologic pathology

Molecular cancer therapeutics

Regeneron Pharmaceuticals Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Regeneron Pharmaceuticals Inc

United States

Fellow, Pathology :: Drug Safety and Pharmacometrics

Publications

Jantine E Bakema, Marijke Stigter van Walsum, Jeffrey R Harris, Sonja H Ganzevles, Anantharaman Muthuswamy, Mischa Houtkamp, Theo S Plantinga, Elisabeth Bloemena, Ruud H Brakenhoff, Esther C W Breij, Rieneke van de Ven
An antibody-drug conjugate directed to tissue factor shows preclinical anti-tumor activity in head and neck cancer as a single agent and in combination with chemoradiotherapy. Molecular cancer therapeutics (2023)
Anantharaman Muthuswamy, Henry Chen, Ying Hu, Oliver C Turner, Olulanu H Aina
Mammalian Retinal Cell Quantification. Toxicologic pathology 49 (3) (2020)
Anantharaman Muthuswamy, Ingrid D Pardo, Deepa B Rao, Robert C Switzer, Alok K Sharma, Brad Bolon
Neuroanatomy and Sampling of Central Projections for the Visual System in Mammals Used in Toxicity Testing. Toxicologic pathology 49 (3) (2020)